Published in PLoS One on August 19, 2014
Chemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation. Org Biomol Chem (2015) 0.75
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med (2000) 7.78
TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol (2006) 3.44
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci U S A (2005) 2.66
Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol (1986) 2.60
Organization of Escherichia coli O157 O antigen gene cluster and identification of its specific genes. Infect Immun (1998) 2.23
Escherichia coli O157:H7 infection in humans. Ann Intern Med (1995) 2.12
The activity of a putative polyisoprenol-linked sugar translocase (Wzx) involved in Escherichia coli O antigen assembly is independent of the chemical structure of the O repeat. J Biol Chem (1999) 2.06
Emerging principles for the therapeutic exploitation of glycosylation. Science (2014) 1.83
The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis (1997) 1.79
Immunology of bacterial polysaccharide antigens. Carbohydr Res (2003) 1.67
Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol (2002) 1.66
Haemolytic-uraemic syndrome complicating shigella dystentery in south Indian children. Br Med J (1978) 1.56
Cloning of the rfb gene cluster of a group C2 Salmonella strain: comparison with the rfb regions of groups B and D. Mol Microbiol (1991) 1.49
Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins. Protein Sci (2001) 1.34
Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact (2010) 1.23
Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med (2012) 1.07
Expression and purification of recombinant proteins by fusion to maltose-binding protein. Mol Biotechnol (2000) 1.06
Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults. J Infect Dis (1998) 1.05
Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. Appl Environ Microbiol (2010) 1.01
Comparative effects of carrier proteins on vaccine-induced immune response. Vaccine (2011) 1.00
Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes. Cancer Res (2005) 0.98
Conjugate vaccines. Expert Rev Vaccines (2003) 0.98
Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis. Microb Cell Fact (2012) 0.98
Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice. Infect Immun (1999) 0.95
Potential role for Toll-like receptor 4 in mediating Escherichia coli maltose-binding protein activation of dendritic cells. Infect Immun (2007) 0.91
Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol (2013) 0.90
Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component. Glycoconj J (2012) 0.90
Parenteral immunization with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 elicits a systemic humoral immune response in mice, but fails to prevent colonization by the pathogen. Can J Microbiol (1999) 0.84
Glycoconjugate vaccines. Expert Opin Biol Ther (2012) 0.83
Oral immunization of mice with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 admixed with cholera toxin fails to elicit protection against subsequent colonization by the pathogen. Can J Microbiol (2000) 0.78
[Isolation of group-specific polysaccharide complexes from group B streptococci by phenol-water extraction]. J Basic Microbiol (1988) 0.77